When Hybridomas Die: Recovering Critical Reagents with Antibody Sequencing
To develop robust mAb biologics, it is vital to fully characterize the protein, including its primary sequence, mutations, and important post-translational modifications
September 2025
April 2025
Anti-Idiotypic Antibodies in Drug Development
Written by: Genya Gorshtein, MSc Published: April 9, 2025 Contents Introduction What Is An Anti-Idiotypic Antibody? Applications of Anti-Idiotypic Antibodies in Drug Development Discovery and Generation of Anti-Idiotypic Antibodies Anti-Idiotype Antibody Discovery with Rapid Novor Introduction Anti-idiotypic antibodies are specialized antibodies that bind to [...]
February 2025
Antibody Tools for Target Identification and Validation
Written by: Genya Gorshtein, MSc Published: February 10, 2025 Contents Introduction Process of Target Identification and Validation Antibodies as Tools for Target ID and Validation Experiments Custom Antibody Development for Target Validation Custom Antibody Services with Rapid Novor Introduction Successful drug discovery begins with [...]